MARK MEADOR

Mark Meador represents clients in high-profile and complex antitrust matters, drawing on his wide-ranging experience working for federal antitrust enforcers and the U.S. Senate Judiciary Committee. His expertise spans antitrust compliance, merger reviews, strategic communications, coalition management, regulatory advocacy, and competition policy counseling.

Mark has led and participated in complex investigations as an antitrust enforcer at both the Federal Trade Commission, in the Bureau of Competition’s Healthcare Division, and in the Transportation, Energy & Agriculture Section of the Department of Justice’s Antitrust Division. He was deeply involved in FTC’s efforts to combat pay-for-delay agreements and product hopping in the pharmaceutical industry. At DOJ, Mark played a key role in several high-profile investigations, including the Division’s successful challenge of Visa/Plaid.

Mark served a total of four years as the senior Republican antitrust attorney for the Senate Judiciary Committee, both as a detailee from FTC and DOJ and as Deputy Chief Counsel for Antitrust & Competition Policy to Sen. Mike Lee. In that role, Mark advised on oversight of federal enforcers and oversaw twenty-one subcommittee hearings covering some of the most high-profile antitrust matters of our time. Mark played a pivotal role in the preparation and review of several landmark antitrust bills, including the State Antitrust Enforcement Venue Act and the Merger Filing Fee Modernization Act passed into law in 2022. He continues to be a sought-after speaker and advisor on conservative antitrust policy.

Mark also previously worked at another major D.C. law firm, where he represented parties appearing before federal and state antitrust enforcers, including in merger, civil, and criminal investigations. Mark provided ongoing antitrust compliance advice to several clients, and was deeply involved multiple matters relating to Big Tech.

At Kressin Meador Powers, Mark continues to engage with cutting-edge antitrust issues. His clients range from startups and individuals to Fortune 500 companies in a wide array of industries, including agriculture, healthcare and pharmaceuticals, technology, insurance, grocery and retail, manufacturing, telecom, finance, and journalism. Mark’s unique experience enables him to advise not only on antitrust compliance and litigation, drawing on his experience as a former enforcer, but also on the policy dimensions of offensive and defensive antitrust strategies. Clients turn to Mark to handle their most complex antitrust matters.

Government Experience

• Federal Trade Commission, Bureau of Competition, Attorney, 2011-2016

• Department of Justice Antitrust Division, Trial Attorney, 2019-2023

• United States Senate, Judiciary Committee, Antitrust Subcommittee, Deputy Chief Counsel for Antitrust and Competition Policy, 2020-2023

Professional Associations & Affiliations

• The Heritage Foundation: Visiting Fellow, Tech Policy Center

• American Bar Association Antitrust Law Section: Vice-Chair, U.S. Comments & Policy Committee

• The Federalist Society: Member, Corporations, Securities & Antitrust Practice Group Executive Committee

Speaking & Publications

• Panelist at DOJ-FTC Joint Workshop: Evolving Approaches to Mergers Between Rivals from the 2010 HMG to the Draft Merger Guidelines (Sept. 5, 2023).

• The Dynamist: Did Google Monopolize Ad-Tech? w/ Mark Meador, The Foundation for American Innovation (August 8, 2023).

• Moment of Truth: Will We Revolutionize Antitrust. (ft. Mark Meador), American Moment (July 31, 2023).

• Our Curious Amalgam: #215 What Does Antitrust Counsel to a United States Senator Do? A Conversation With Mark Meador, American Bar Association (Apr. 23, 2023).

• Panelist at ABA Antitrust Law Section Fall Forum panel: Legislative Reform—Competition Policy as Staple Gun (Nov. 17, 2022).

• Panelist at Competition Policy International panel: Challenges in Merger Enforcement—Where Next? (Nov. 16, 2022).

• Panelist at Bipartisan Policy Center panel: Big Tech and M&A: Killer Acquisitions and Kill Zones? (Oct. 31, 2022).

• Panelist at ABA Antitrust Law Section Legislation Committee panel: Update on the State Antitrust Enforcement Venue Act (July 11, 2022).

• Keynote Address at the GW Regulatory Studies Center and Information Technology and Innovation Foundation Conference: Dynamic Competition and Public Policy (April 14, 2022).

• Panelist at the George Mason Law Review and Global Antitrust Institute 25 Years of Antitrust Symposium: Proposals to Change the Antitrust Laws (Feb. 25, 2022).

• Mark R. Meador, Squeezing the Middleman: Ending Underhanded Dealing in the Pharmacy Benefit Management Industry Through Regulation, 21 ANN. HEALTH LAW 77 (2011).